Alkeus Pharma
Jun 22, 2020
Mapping The Pipeline Development In The Geographic Atrophy Market
The Geographic atrophy market size is anticipated to increase during the study period 2017–2030 owing to increasing GA prevalence, better understanding of disease pathophysiology, better therapies and pipeline candidates aimed at addressing the disease from its root. Geographic Atrophy (GA) is an advanced form ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
